1872, Domestic Various: Volume 161:105
0000 - Gale Group | NCCO AsiaWest
Liang Zhang, Zhuang Tong, Ruizheng Han, Kaixiang Li, Xin Zhang, Ruixia Yuan,
... life years (DALYs) of RHD were 37.39/105 (95%UI, 28.59/105 to 46.74/105), 513.68/105 (95%UI, 405.01/105 to 636.25/105), 3.85/105 (95%UI, 4.29/105 to 3.29/105) and 132.88/105 (95%UI, 115.02/105 to 150.34/ ...
Tópico(s): Antimicrobial Resistance in Staphylococcus
2023 - Elsevier BV | International Journal of Cardiology
Volume 105 : Apr. 10, 1843-Apr. 29, 1845
1845 - Gale Group | SASII
Chen Tan, Min Chen, Chen Zou, Changle Chen,
... monomers and produce high-molecular-weight copolymers (Mn > 105 g·mol−1).16 They can also lead ... Some of these systems exhibit high copolymerization activities (>105 g·mol−1·h−1), high copolymer molecular ... ratio of polar monomer are in units of 105 g·mol−1·h−1, kg·mol−1, ... catalysts showed high activities (up to 6.4 × 105 g·mol−1·h−1), moderate molecular weights ( ... to high copolymerization activities (up to 1.9 × 105 g·mol−1·h−1) at ∼100–120 ° ... ratio ∼39–50 mol %) with high copolymerization activities (>105 g·mol−1·h−1) at 110 °C ...
Tópico(s): biodegradable polymer synthesis and properties
2023 - Chinese Chemical Society | CCS Chemistry
Volume 105 : Apr. 10, 1843-Apr. 29, 1845
1845 - Gale Group | SASII
Jialin Xie, Xia Li, Zhenglin Du, Yandie Liu, Kelong Zhu,
... v/v) pyridine/ice water and stirred at 105 °C for another 15 h. After the reaction ... 80 °C for 60 h, then pyridine/H2O, 105 °C for 15 h. Download figure Download PowerPoint ... Ka was calculated to be ca. 3.7 × 105 M−1 (Table 1).66 Single crystals of ... 1.3 × 104 M−1c K1 = 1.7 × 105 M−1c K1 = 8.0 × 105 M−1d K2 = 2.8 × 105 M−1 K2 = 3.5 × 106 M−1 ... 82 α = 0.075 1b Ka = 3.7 × 105 M−1e K1 = 2.3 × 105 M−1d K2 = 5.8 × 103 M−1 ... constants were estimated to be K1 = 1.7 × 105 M−1 and K2 = 3.5 × 106 M− ... Ka values were calculated to be 2.3 × 105 M−1 and 5.8 × 103 M−1, ...
Tópico(s): Boron and Carbon Nanomaterials Research
2022 - Chinese Chemical Society | CCS Chemistry
Springer Link
Volume 105 : Apr. 10, 1843-Apr. 29, 1845
1845 - Gale Group | SASII
Bo Lin, Chunhua Liu, Enyi Shi, Jin Qiu, Wenhui Zhao, Juan Wang, Runyuan Ji,
... study was to explore the effect of miR-105-3p on the tumourigenicity of breast cancer and ... was applied to detect the expression of miR-105-3p in breast cancer tissues and cell lines. The impacts of miR-105-3p on the proliferation, migration, invasion and apoptosis ... used to determine the target genes of miR-105-3p. Results The expression of miR-105-3p was elevated in breast cancer tissues and increased with tumour severity. Downregulation of miR-105-3p could inhibit cell proliferation, suppress cell migration/ ...
Tópico(s): RNA modifications and cancer
2021 - BioMed Central | BMC Cancer
Volume 105 : Apr. 10, 1843-Apr. 29, 1845
1845 - Gale Group | SASII
Vladimir J. Lozanovski, Pascal Probst, Alireza Arefidoust, Ali Ramouz, Ehsan Aminizadeh, Mohammadsadegh Nikdad, Elias Khajeh, Omid Ghamarnejad, Saeed Shafiei, Sadeq Ali‐Hasan‐Al‐Saegh, Svenja Seide, Eva Kalkum, Arash Nickkholgh, Zoltán Czigány, Georg Lurje, Markus Mieth, Arianeb Mehrabi,
... partial/split) + (0.066 ((170–height)/10)) + (0.105 if regional share) + (0.244 if national share) + ( ... partial/split) + (0.066 ((170–height)/10)) + (0.105 if regional share) + (0.244 if national share) + ( ... partial/split) + (0.066 ((170–height)/10)) + (0.105 if regional share) + (0.244 if national share) + ( ... partial/split) + (0.066 ((170–height)/10)) + (0.105 if regional share) + (0.244 if national share) + ( ... partial/split) + (0.066 ((170–height)/10)) + (0.105 if regional share) + (0.244 if national share) + ( ... partial/split) + (0.066 ((170–height)/10)) + (0.105 if regional share) + (0.244 if national share) + ( ...
Tópico(s): Renal Transplantation Outcomes and Treatments
2021 - Springer Science+Business Media | Transplant International
1869, Foreign: Volume 105:1
0000 - Gale Group | NCCO AsiaWest
Victoria David, Michael Walsh, Jocelyn Lockyer, Marcy Mintz,
... trainees were not actionable (94.3%, n = 99/105). While most residents did not comment on value (73.3%, n = 77/105) or disruption (44.8%, n = 47/105) of the encounter, those that did generally found the encounters valuable (25.7%, n = 27/105) and nondisruptive (35.2%, n = 37/105). A minority found the process nonvaluable (1%, n = 1/105) and disruptive (20%, n = 21/105). The mean time to complete an EPA form ... codée en fonction de l’exploitabilité. RésultatsAu total, 105 rencontres d’APC ont été soumises. La majorité ... n’étaient pas exploitables (94,3 %, n = 99/105). Bien que la plupart des résidents n’aient ...
Tópico(s): Clinical Reasoning and Diagnostic Skills
2021 - | Canadian Journal of General Internal Medicine
Volume 105 : Apr. 10, 1843-Apr. 29, 1845
1845 - Gale Group | SASII
Xinxin Kou, Hui Ding, Lei Li, Hongtu Chao,
... In this study, we examined how Hsa-miR-105-1 functions in cisplatin-resistant OC cells.The levels of Hsa-miR-105-1 expression in cisplatin-sensitive and resistant OC ... qRT-PCR. The target gene of Hsa-miR-105-1 was predicted by using the TargetScan and ... gene assay. The target gene of Hsa-miR-105-1 was identified as ANXA9, and ANXA9 expression ... immunofluorescence. To validate the function of Hsa-miR-105-1 in OC cells, we silenced or overexpressed Hsa-miR-105-1 in cisplatin-sensitive or resistant OC cell ...
Tópico(s): RNA Research and Splicing
2021 - Springer Science+Business Media | Analytical Cellular Pathology
Volume 105 : Apr. 10, 1843-Apr. 29, 1845
1845 - Gale Group | SASII
Christopher L. Smith, Mandi Liu, Madhumitha Saravanan, Aaron G. DeWitt, David M. Biko, Erin Pinto, Fernando Escobar, Ganesh Krishnamurthy, Jefferson N. Brownell, Petar Mamula, Andrew C. Glatz, Matthew J. Gillespie, Michael L. O’Byrne, Chitra Ravishankar, Jonathan J. Rome, Yoav Dori,
... hepatic lymphatics were performed.During the study period, 105 patients underwent intra-hepatic lymphangiography. Primary clinical presentation included ascites (19/105), chylothorax (27/105), plastic bronchitis (PB) (17/105), and protein losing enteropathy (PLE) (42/105). Five categories of hepatic lymphatic connections and flow patterns were identified (%): normal (25%, 26/105), hepatoperitoneal (12%, 13/105), hepatopulmonary (10.5%, 11/105), hepatomesenteric (7.5%, 8/105), and hepatoduodenal (41%, 43/105) with four patients ...
Tópico(s): Cystic Fibrosis Research Advances
2021 - Springer Science+Business Media | European Radiology
Volume 105 : Apr. 10, 1843-Apr. 29, 1845
1845 - Gale Group | SASII
Yan‐Long Ma, Mao Quan, Xiulian Lin, Qian Cheng, Huan Yao, Xiran Yang, Ming‐Shuang Li, Wei‐Er Liu, Linming Bai, Ruibing Wang, Wei Jiang,
... 18.3 ± 0.2 (9.5 ± 0.5) × 105 −34.1 ± 0.1 194b −13.1c 2 − ... 24.2 ± 0.1 (8.6 ± 0.3) × 105 −33.9 ± 0.1 214b −13.3c 3 − ... 23.5 ± 0.1 (1.1 ± 0.1) × 105 −28.7 ± 0.1 279b −14.0c 5 − ... 28.1 ± 0.1 (3.1 ± 0.1) × 105 −31.3 ± 0.1 38d,e,f −9. ... 14.8c 17 —h (1.0 ± 0.1) × 105 −28.5 ± 0.2 (3.9 ± 0.3) × 105 −31.9 ± 0.2 368d,f −14.6 ... 27.9 ± 0.1 (7.0 ± 0.1) × 105 −33.4 ± 0.1 —d,e,g 339 ± ... 23.6 ± 0.1 (3.2 ± 0.2) × 105 −31.3 ± 0.1 (1.9 ± 0.1) × ... 27.9 ± 0.1 (3.1 ± 0.1) × 105 −31.3 ± 0.1 (1.6 ± 0.1) × ... 104d,e −23.7c (3.3 ± 0.1) × 105 −31.4 ± 0.1 60 ± 17d,e −10. ...
Tópico(s): Malaria Research and Control
2020 - Chinese Chemical Society | CCS Chemistry
Volume 105 : Apr. 10, 1843-Apr. 29, 1845
1845 - Gale Group | SASII
Dennis Lund Hansen, Andreas Glenthøj, Sören Möller, Bart J. Biemond, Kjeld Andersen, David Gaist, Jesper Petersen, Henrik Frederiksen,
... times between 2000 and 2015, from 10.2/105 persons to 17.7/105 persons. Alpha thalassemia trait had a prevalence of 0.5/105 persons in 2000, but increased 41 times to 19.2/105 persons in 2015. Beta thalassemia minor increased eightfold from 4.5/105 persons in 2000 to 34.9/105 persons in 2015. Likewise, sickle cell trait increased 11 times from 0.7/105 persons in 2000 to 8.1/105 persons in 2015, whereas sickle cell disease increased from 0.5/105 persons to 2.7/105 persons in 2015, a fivefold increase.The prevalence ...
Tópico(s): Neonatal Health and Biochemistry
2020 - Dove Medical Press | Clinical Epidemiology